seems like your trying to justify your selling CT - notice you no longer hold
the sellers at these levels with regret it in a month IMO
derisking at 1.9c ? just north of the 52 week lows
lets consider what irons ALT had in the fire at 2c when it last raised cash ? no brazilian trials, no negotiations with US majors, no marketing in south east asia, no mention of China and Middle East ... just a product
we now have all that and people sell at 1.9c ?
pricing in dissapointing results ? the trials haven't even begun yet !
you don't sell the resource stock before it even drills. you derisk leading up to assays being released and ride the run / speculation leading to results
if anything, now is the opportune time to buy knowing that they will shortly confirm trials are beginning and have advised the market that a distribution deal should be signed in April - it will run leading up to the end of the month
- Forums
- ASX - By Stock
- ALT
- Ann: App 4D and Half Year financial report
Ann: App 4D and Half Year financial report , page-6
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online